{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T08:33:08Z","timestamp":1788942788396,"version":"build-2803163510"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Prostate cancer is the fifth leading cause of death in the male population worldwide. <jats:sup>68<\/jats:sup>Ga-PSMA PET\/CT has proved to be an excellent modality with greater accuracy for nodal and bone\/visceral metastases staging than bone scintigraphy and CT scan, with high sensitivity and specificity. Common sites of metastasis include bone (84%), lymph nodes (10.6%), liver (10.2%), lung, and pleura (9.1%); however, metastasis to the skin is quite rare (\u22640.36%). The present case demonstrates PSMA-avid perineal metastasis in a patient of prostate cancer postchemoradiotherapy on <jats:sup>68<\/jats:sup>Ga-PSMA PET\/CT scan.<\/jats:p>","DOI":"10.1097\/rlu.0000000000004987","type":"journal-article","created":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T06:00:19Z","timestamp":1701756019000},"page":"e73-e74","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Unusual Perineal Metastasis in a Case of Prostate Cancer on 68Ga-PSMA-11 PET\/CT"],"prefix":"10.1097","volume":"49","author":[{"given":"Ritanshu","family":"Solanki","sequence":"first","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhagwant Rai","family":"Mittal","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajender","family":"Kumar","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aravindh","family":"Sekar","sequence":"additional","affiliation":[{"name":"Histopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narender","family":"Kumar","sequence":"additional","affiliation":[{"name":"Radiation Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,12,4]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0140-6736(20)30314-7","article-title":"Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study","volume":"395","year":"2020","journal-title":"Lancet"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.eururo.2019.01.049","article-title":"Gallium-68 prostate-specific membrane antigen positron emission tomography in advanced prostate cancer-updated diagnostic utility, sensitivity, specificity, and distribution of prostate-specific membrane antigen-avid lesions: a systematic review and meta-analysis","volume":"77","year":"2020","journal-title":"Eur Urol"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/pros.22742","article-title":"Distribution of metastatic sites in patients with prostate cancer: a population-based analysis","volume":"74","year":"2014","journal-title":"Prostate"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/RLU.0000000000004469","article-title":"PSMA-PET detection of unusual metastases in castrate-sensitive prostate carcinoma","volume":"48","year":"2023","journal-title":"Clin Nucl Med"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4132\/jptm.2016.06.14","article-title":"Differential immunohistochemical profiles for distinguishing prostate carcinoma and urothelial carcinoma","volume":"50","year":"2016","journal-title":"J Pathol Transl Med"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1148\/radiol.204066","article-title":"Safety and diagnostic yield of 68Ga prostate-specific membrane antigen PET\/CT-guided robotic-assisted transgluteal prostatic biopsy","volume":"303","year":"2022","journal-title":"Radiology"},{"key":"bib8-20250621","first-page":"92","article-title":"The role of radiotherapy in metastatic prostate cancer","volume":"7","year":"2019","journal-title":"Am J Clin Exp Urol"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1200\/OP.21.00206","article-title":"Recent advances in the management of metastatic prostate cancer","volume":"18","year":"2022","journal-title":"JCO Oncol Pract"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004987","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T19:02:55Z","timestamp":1750532575000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,4]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000004987","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,4]]}}}